[vc_row][vc_column][vc_column_text] Excitement spread quickly after a June 14 report that a COVID-19 vaccine developed by Imperial College London in the U.K. will be tested in humans. What excites people is that the vaccine, which is based on a cutting-edge technology called self-amplifying RNA, could be produced...
[vc_row][vc_column][vc_column_text] Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate for an effective COVID-19 treatment. A report published in The New England Journal of Medicine on May 22 revealed that the once...
[vc_row][vc_column][vc_column_text] Learn about recent advances in the field of immunotherapy, including how some treatments are now being leveraged to combat other infectious diseases, including COVID-19. Did you know that your best defense against illness and disease is already at work inside of you? Your immune system --...
[vc_row][vc_column][vc_column_text] Early in February, Dr. Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health, noticed a sex difference in COVID-19 infections based on reports emerging from China. She felt that men might have a...
[vc_row][vc_column][vc_column_text] Note: This is part two of Dr. Michael Wang's series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. In addition to surgery, radiation therapy and chemotherapy are the other two major medical procedures to treat brain cancers. Patients...
[vc_row][vc_column][vc_column_text] With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices and guidelines pertaining to brain cancer and COVID-19. Glioblastoma, also known as glioblastoma multiforme (GBM), is the most aggressive type of brain tumor....
[vc_row][vc_column][vc_column_text] With a phased reopening starting last week in select geographies, cancer patients and cancer survivors in those areas who have to go back to work will face a higher risk of developing COVID-19. The quickened loosening of social distancing restrictions will expose more people to...
April is normally a busy month. As previews of spring start popping up across the nation and the long winter hibernations end, people begin feeling an itch to get out in newly-discovered sunlight. The country uses this burst of energy to celebrate National Volunteers Month...
FOR IMMEDIATE RELEASE: April 14, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD –The National Foundation for Cancer Research (NFCR) has launched an online resource center targeted especially to cancer patients and caregivers during the COVID-19...
[vc_row][vc_column][vc_column_text] The recently announced extension of social distancing guidelines through the end of April is an important step taken by the U.S. federal government to slow down the spread of coronavirus. But the overall picture of the COVID-19 pandemic is still very serious, and cancer patients...
Search NFCR
Popular searches